Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

Migraine

Free Subscription Articles published in JAMA Retrieve available abstracts of 12 articles: HTML format

Single Articles

August 2022
1. SLOMSKI A
   Monoclonal Antibody Overcomes Migraine Treatment Failure.
   JAMA. 2022;328:700.
   PubMed    
   
   
   March 2022
2. SLOMSKI A
   Erenumab Safe, Effective for Patients With Migraine With Aura.
   JAMA. 2022;327:804.
   PubMed    
   
   
   January 2022
3. WALTER K
   What Is Migraine?
   JAMA. 2022;327:93.
   PubMed    
   
   
   October 2021
4. HAGAN JC 3RD
   Systematic Review and Meta-analysis of Acute Treatments for Episodic Migraine in Adults.
   JAMA. 2021;326:1636.
   PubMed    
   
   
   
5. MOISSET X, Demarquay G, Ducros A
   Systematic Review and Meta-analysis of Acute Treatments for Episodic Migraine in Adults.
   JAMA. 2021;326:1636-1637.
   PubMed    
   
   
   
6. WANG Z, VanderPluym JH, Murad MH
   Systematic Review and Meta-analysis of Acute Treatments for Episodic Migraine in Adults-Reply.
   JAMA. 2021;326:1637.
   PubMed    
   
   
   August 2021
7. SLOMSKI A
   Diets High in Omega-3 Fatty Acids Might Ease Migraines.
   JAMA. 2021;326:691.
   PubMed    
   
   
   June 2021
8. BURCH R, Rayhill M
   Acute Treatment for Migraine: Contemporary Treatments and Future Directions.
   JAMA. 2021;325:2346-2347.
   PubMed    
   
   
   
9. WINNER PK, McAllister P, Chakhava G, Ailani J, et al
   Effects of Intravenous Eptinezumab vs Placebo on Headache Pain and Most Bothersome Symptom When Initiated During a Migraine Attack: A Randomized Clinical Trial.
   JAMA. 2021;325:2348-2356.
   PubMed     Abstract available
   
   
   
10. VANDERPLUYM JH, Halker Singh RB, Urtecho M, Morrow AS, et al
    Acute Treatments for Episodic Migraine in Adults: A Systematic Review and Meta-analysis.
    JAMA. 2021;325:2357-2369.
    PubMed     Abstract available
    
    
    May 2021
11. ROBBINS MS
    Diagnosis and Management of Headache: A Review.
    JAMA. 2021;325:1874-1885.
    PubMed     Abstract available
    
    
    February 2021
12. SLOMSKI A
    Oral Rimegepant Safe, Effective for Migraine Prevention.
    JAMA. 2021;325:713.
    PubMed    
    
    

Thank you for your interest in scientific medicine.

AMEDEO Migraine is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: